A Phase I Dose per Fraction Escalation Study of Hypofractionated Intensity-modulated Radiation Therapy with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma

被引：0
|
作者：
Chen, C. [1 ]
Damek, D. [1 ]
Waziri, A. [1 ]
Gaspar, L. E. [1 ]
Lillehei, K. [1 ]
Kane, M. [1 ]
Robischon, M. [1 ]
Kavanagh, B. [1 ]
机构：
[1] Univ Colorado Denver, Aurora, CO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] PHASE I TRIAL OF DOSE PER FRACTION ESCALATION OF HYPOFRACTIONATED IMRT WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise M.
    Waziri, Allen E.
    Gaspar, Laurie Elizabeth
    Lillehei, Kevin O.
    Kane, Madeleine
    Robischon, Monica
    Kavanagh, Brian
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 662 - 662
  • [2] PHASE I TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Waziri, Allen
    Lillehei, Kevin
    Kleinschmidt-DeMasters, B. K.
    Robischon, Monica
    Stuhr, Kelly
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1066 - 1074
  • [3] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Douglas E. Ney
    Julie A. Carlson
    Denise M. Damek
    Laurie E. Gaspar
    Brian D. Kavanagh
    B. K. Kleinschmidt-DeMasters
    Allen E. Waziri
    Kevin O. Lillehei
    Krishna Reddy
    Changhu Chen
    [J]. Journal of Neuro-Oncology, 2015, 122 : 135 - 143
  • [4] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Ney, Douglas E.
    Carlson, Julie A.
    Damek, Denise M.
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Kleinschmidt-DeMasters, B. K.
    Waziri, Allen E.
    Lillehei, Kevin O.
    Reddy, Krishna
    Chen, Changhu
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (01) : 135 - 143
  • [5] Hypofractionated intensity-modulated radiation therapy and temozolomide for patients with glioblastoma
    Souhami, Luis
    Roberge, David
    Kavan, Petr
    Muanza, Thierry
    Lambert, Christine
    Guiot, Marie Christine
    Del Maestro, Rolando
    Leblanc, Richard
    Shenouda, George
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 583 - 583
  • [6] Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed Glioblastoma
    Tsien, Christina I.
    Brown, Doris
    Normolle, Daniel
    Schipper, Matthew
    Piert, Morand
    Junck, Larry
    Heth, Jason
    Gomez-Hassan, Diana
    Ten Haken, Randall K.
    Chenevert, Thomas
    Cao, Yue
    Lawrence, Theodore
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (01) : 273 - 279
  • [7] Phase 1 TITE-CRM Dose Escalation Study of Concurrent Temozolomide and Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme
    Brown, D. R.
    Normolle, D.
    Junck, L. R.
    Lawrence, T. S.
    Heth, J. A.
    Hayman, J. A.
    Ten Haken, R. K.
    Chenevert, T.
    Piert, M. R.
    Tsien, C. I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S124 - S124
  • [8] Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Iuchi, Toshihiko
    Hatano, Kazuo
    Kodama, Takashi
    Sakaida, Tsukasa
    Yokoi, Sana
    Kawasaki, Koichiro
    Hasegawa, Yuzo
    Hara, Ryusuke
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (04): : 793 - 800
  • [9] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [10] Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
    Jastaniyah, Noha
    Murtha, Albert
    Pervez, Nadeem
    Le, Duc
    Roa, Wilson
    Patel, Samir
    Mackenzie, Marc
    Fulton, Dorcas
    Field, Colin
    Ghosh, Sunita
    Fallone, Gino
    Abdulkarim, Bassam
    [J]. RADIATION ONCOLOGY, 2013, 8
12345